Engmann, L L <br/><br/>
Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.  [electronic resource] 

 -  Journal of ovarian research  Jan 2019 
 - 8 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1757-2215 
<br/><br/><label>Standard No.: </label>10.1186/s13048-019-0483-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Chorionic Gonadotropin--administration & dosage<br/>Double-Blind Method<br/>Female<br/>Fertilization in Vitro<br/>Gonadotropin-Releasing Hormone--agonists<br/>Humans<br/>Live Birth<br/>Ovarian Hyperstimulation Syndrome--chemically induced<br/>Ovulation Induction--methods<br/>Pregnancy<br/>Pregnancy Rate<br/>Prospective Studies<br/>Risk